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The swine-origin pandemic (p) H1N1 influenza A virus causes mild upper-respiratory tract disease in most human
patients. However, some patients developed severe lower-respiratory tract infections with fatal consequences,
and the cause of these infections remain unknown. Recently, it has been suggested that different populations
have different degrees of susceptibility to pH1N1 strains due to host genetic variations that are associated with
inappropriate immune responses against viral genetic characteristics. Here, we tested whether the pathologic
patterns of influenza strains that produce different disease outcomes in humans could be reproduced in a ferret
model. Our results revealed that the severities of infection did not correspond to particular viral isolate and
were not associated with the clinical phenotypes of the corresponding patients. Severe pathological outcomes
were associated with higher viral replication, especially in alveolar areas, and with an exacerbated innate cellular
immune response that was characterised by substantial phagocytic and cytotoxic cell migration into the lungs.
Moreover, detrimental innate cellular responses were linked to the up-regulation of several proinflammatory cytokines
and chemokines and the down-regulation of IFNα in the lungs. Additionally, severe lung lesions were associated with
greater up-regulations of pro-apoptotic markers and higher levels of apoptotic neutrophils and macrophages. In
conclusion, this study confirmed that the clinicopathological outcomes of pH1N1 infection in ferrets were not
only due to viral replication abilities but also depended on the hosts’ capacities to mount efficient immune
responses to control viral infection of the lung.Introduction
In 2009, the swine-origin H1N1 influenza A virus (IAV)
emerged and caused outbreaks of respiratory illness
in humans around the world, and the World Health
Organisation (WHO) declared a worldwide pandemic [1].
In contrast to seasonal influenza, which is more likely to
cause severe illness in the elderly, children and immu-
nocompromised patients, the pandemic H1N1 (pH1N1)
caused serious disease in young adults and previously* Correspondence: beatriz.vidana@cresa.uab.cat
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unless otherwise stated.healthy individuals [2–4]. This phenomenon was related
with the presence of cross-neutralising antibodies against
pH1N1 in the elderly population but not in children and
young adults [5].
The physiopathology of pH1N1 infection in humans
differs across individuals. Whilst most patients devel-
oped mild upper respiratory-tract infection, some patients
progressed to develop severe lower respiratory-tract com-
plications with fatal consequences [4,6]. The cause of death
in the severe cases was identified as a consequence of dif-
fuse alveolar damage (DAD), which is also termed acute
interstitial pneumonia [7].
The striking heterogeneity of the clinicopathological
outcomes observed after pH1N1 infection in humans
lead to numerous studies initially focused on the impactLtd. This is an Open Access article distributed under the terms of the Creative
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infection. Virulence markers have been mapped to the
polymerase genes (PB1, PB2 and PA), neuraminidases
(NAs), and the non-structural proteins (NS1s) of the
highly pathogenic avian influenza viruses and the 1918
pandemic H1N1 strains [8]. Recently, it has also been
suggested that genetic polymorphisms that affect the
polymerase complex and the hemagglutinin (HA) sub-
unit may contribute to the pathogenicity of certain
pH1N1 strains by conferring on them the ability to pro-
duce higher viral titres or the ability to replicate over a
prolonged period of time [9,10]. The viral strains used in
this work have been sequenced, and several mutations
have been found in each of the viral strains [11]. How-
ever, the importance of these mutations in the pathogen-
icity of pH1N1 still needs to be clarified [11].
In contrast, several reports have suggested that
influenza-associated pathology is most strongly deter-
mined by the different host factors [12–14]. Host genetic
variation in immune-related genes has been shown to ac-
count for varying susceptibilities to numerous infectious
agents and may contribute to the variation observed in
pH1N1 susceptibility and disease severity [14–16]. A var-
iety of studies have suggested that these host characteris-
tics are associated with appropriate immune responses
that may play important roles in determining the out-
come of infection [13,17–19]. To date, polymorphisms in
the chemokine receptor type (CCR) 5, toll like receptor
(TLR) 3, tumour necrosis factor (TNF) and interferon-
inducible transmembrane (IFITM) genes [15,20–22] and
a deficiency in the immunoglobulin (Ig) G2 response
[23,24] have been correlated with more severe courses of
pH1N1 infection.
This study attempted to clarify whether the variance in
virulence of pH1N1 isolates in humans significantly cor-
relates with the clinicopathological outcome in an ani-
mal model of influenza infection. The aim of this study
was accomplished by experimentally infecting ferrets
with two pH1N1 isolates from two human patients who
developed different clinical outcomes. The viral dynam-
ics and host immune responses of the lungs of the in-
fected ferrets were thoroughly investigated. Assessments
of the pathologic patterns of the lungs and measure-
ments of immune cell and cytokine responses and apop-
totic cell induction were performed to identify the factors
involved in the outcome of this disease.
Material and methods
Viruses
Two strains of human pH1N1 2009 IAV which had been
isolated from geographically similar locations were
used in the present study. The viruses were isolated
at the National Influenza Centre, Centro Nacional de
Microbiología, Instituto de Salud Carlos III (CNM, ISCIII)from respiratory samples sent by the Spanish Influenza
Surveillance System for virological characterisation.
The pH1N1 2009 subtype isolates A/CastillaLaMancha/
RR5661/2009 and A/CastillaLaMancha/RR5911/2009 were
isolated from respiratory samples of two patients who were
both Caucasian and free of previous co-morbid conditions
at the time of infection. Hereafter, the following designa-
tions will be used: virus R61 for the A/CastillaLaMancha/
RR5661/2009 virus, which was isolated from a 23-year old
man exhibiting mild respiratory disease, and virus R11 for
the A/CastillaLaMancha/RR5911/2009 virus, which was
isolated from a 35-year old woman who developed a severe
disease that resulted in a fatal outcome. Both viruses
were isolated via bronchoalveolar lavage as described
by Rodríguez et al. [11] and were passaged three times
in Madin-Darby Canine kidney (MDCK) cells. The R61
virus had a titre of 108.3 50% Tissue Culture Infective
Dose (TCID50) per mL, and the R11 virus had a titre
of 108.2 TCID50/mL as determined with the Reed and
Muench method [25].
Ferrets
Ten ferrets between the ages of twelve and twenty-four
months that were seronegative for influenza A virus
(influenza A antibody competition multi-species ELISA, ID
Screen®, France) and Aleutian disease virus were randomly
selected from a stable, purposely bred colony (Isoquimen,
Spain). Upon arrival at the Centre de Recerca en Sanitat
Animal (CReSA), the animals were placed in biosafety level
3 (BSL-3) facilities. The ferrets were randomly assigned to
different experimental groups, separated into experimental
isolation rooms and then maintained for one week for ac-
climation. The animals were maintained in standard hous-
ing cages and provided with commercial food pellets and
tap water ad libitum throughout the experiment. All ex-
periments were performed under a protocol (n° 1976) that
was reviewed and approved by the Animal and Human
Experimentation Ethics Commission of the Universitat
Autònoma de Barcelona. All ferrets were monitored daily
for clinical signs, and any animal that was determined
to be in a moribund state was ethically euthanized. Any
animal losing 25% of its original body weight or pre-
senting severe respiratory signs such as severe tachypnea,
nasal and conjunctival exudates and/or severe apathy
(irresponsiveness to external stimulus) were considered
to be in a moribund state and was humanely euthanized.
Anorexia was measured daily by observing the amount of
faeces and the amount of food that needed to be replaced
and the attitude of the animals towards food. Depression
was evaluated with reference to the activity of the ani-
mals and their response to external stimulus (such as
sound or human presence). Tachypnea was considered
when respiratory rate was higher than 70 breaths per mi-
nute, accompanied by abdominal breathing.
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trol group included two ferrets that were inoculated
intratracheally with 0.1 M phosphate-buffered saline
(pH = 7.5) (PBS). The R61 group included 4 ferrets that
were infected with the R61 virus, and the R11 group
included 4 ferrets that were infected with the R11 virus.
The ferrets were intratracheally inoculated with 106
TCID50/mL of the appropriate virus, and necropsies
were performed on days 4 and 7 postinfection. The ani-
mals were euthanized by intravenous injection of sodium
pentobarbital (100 mg/kg) under anaesthesia with keta-
mine (5–10 mg/kg) (Imalgene 1000® Merial, S.A., Spain)
and medetomidine (0.05 mg/kg) (Domtor® Pfiser, S.A.,
Spain) and were then necropsied according to a standard
protocol.
Histopathology
Right lung lobe sections (cranial, medial and caudal),
nasal turbinate and trachea were taken for histological
examination according to standard protocols. The tis-
sues were fixed for 48 h in neutral-buffered 10% forma-
lin, then embedded in paraffin wax, sectioned at 3 μm,
and stained with haematoxylin and eosin (HE) for exam-
ination by light microscopy.
Cross sections of the cranial, middle and caudal pul-
monary lobes of each animal were separately evaluated,
and semiquantitative assessments of IAV-associated
microscopic lesions in the lungs were performed. The
lesional scoring was graded on the basis of lesion severity
as follows: grade 0 (no histopathological lesions observed),
grade 1 (mild to moderate necrotising bronchiolitis), grade
2 (bronchointerstitial pneumonia characterised by necro-
tising bronchiolitis and diffuse alveolar damage in adjacent
alveoli), and grade 3 (necrotising bronchiolitis and diffuse
alveolar damage in the majority of the pulmonary paren-
chyma). Microscopic lesional scores were assigned for
each lobe, and the means of the three lobes were used for
the final histopathological score for each animal. Animals
with lung lesion scores over 2 that presented with diffuse
alveolar damage in at least 2 of the examined lung lobes
were considered to have presented with severe lung le-
sions, and animals with scores below 2 were considered to
have developed mild lung lesions.
Viral detection and quantification
For detection of influenza A virus IAV antigen by immu-
nohistochemistry (IHC), the tissues were stained with
a primary antibody against the influenza A nucleopro-
tein (NP) as previously described [26]. Briefly, an anti-
gen retrieval step was performed using protease XIV
(Sigma-Aldrich, UDA) for 10 min at 37 °C and then
blocked for 1 h with 2% bovine serum albumin (85040C,
Sigma-Aldrich Química, S.A., Spain) at room temperature
(RT). Samples were then incubated with a commerciallyavailable mouse-derived monoclonal antibody (ATCC,
HB-65, H16L-10-4R5) concentration (343 mg/mL) as
primary antibody at a dilution of 1:100 at 4 °C over-
night followed by 1 h incubation with biotinylated goat
antimouse IgG secondary antibody (Dako, immunoglob-
ulins As, Denmark). Finally, an avidin-biotin-peroxidase
complex (ABC) system (thermo Fisher Scientific, Rockjord,
IL, USA) was used and the antigen –antibody reaction was
visualized with 3.3′-diaminobenzidine tetrahydrochloride
(DAB) such as chromogen. Sections were counterstained
with Mayer’s Haematoxylin. Positive control consisted of
formalin-fixed paraffin-embedded heart of chicken experi-
mentally infected with influenza. The same sections in
which the specific primary antibodies were substituted
with PBS were used as negative controls. Semiquantitative
assessments of influenza virus antigen expression in the
lungs were performed, and the results were correlated
with the lesional patterns. The positive cells in 6 arbitrar-
ily chosen 20× objective fields in alveolar areas and 5 ar-
bitrarily chosen 20× objective fields in bronchial or
bronchiolar areas were quantified separately in each lung
lobe (cranial, medial and caudal) for every animal. The
mean of the total cell counts per field across the three
lobes was calculated for each animal. The viral loads in
the lung tissues were assessed by quantitative Reverse
Transcription quantitative Polymerase Chain Reaction
(RT-qPCR) following a Taq-Man one-step RT-qPCR per-
formed with Fast 7500 equipment (Applied Biosystems,
Foster city, CA, USA) as described previously [27]. Viral
RNA was extracted with QIAamp viral mini kit (Qiagen,
Valencia, CA, USA) obtaining 60 μL of eluted viral RNA.
The matrix gene (M) fragment amplification was carried
out using the primers showed in Table 1 and One-Step
RT-PCR Master Mix Reagents (Applied Biosystems) fol-
lowing the manufacturer’s instructions using 5 μL of
eluted RNA in a total volume of 25 μL. The amplification
conditions were as follows: reverse transcription at 48 °C
for 30 min; initial denaturation reaction at 95 °C for
15 min and 40 PCR-cycles of 95 °C 15 s and 60 °C 1 min.
Standard curves and quantification were achieved by prior
amplification of a 99 bp fragment of the M gene using
One Step RT-PCR reagents (Qiagen) following manufac-
turer’s instructions. The M gene fragment amplicon
obtained was cloned into pGEMT vector (Promega,
Madison, WI, USA) and transformed by heat shock in
Escherichia coli competent cells (Invitrogen, Paisley, UK).
The recombinant plasmid was purified using the QIA prep
Spin kit (Qiagen) and spectrophotometrically quantified
(Qubit, Invitrogen) as described previously [28]. Serial 10-
fold dilutions of both plasmids of known concentration
were made and the standard curves were generated. The
genome equivalent copies (GEC) of plasmid from the col-
lected samples were determined based on these standard
curves and by taking their volumes into account.
Table 1 Ferret-specific gene primers with publication sources or database names and accession numbers
Gene Primer Sequence (5′- 3′) Publication source or NCBI accession n°
pH1N1 (2009) M + 25 F:AGATGAGTCTTCTAACCGAGGTCG R:TGCAAAGACACTTTCCAGTCTCTG [27]
M-124 human09
M + 64: Probe:FAMa-TCAGGCCCCCTCAAAGCCGA-TAMRAb
IFNα F:TCTCCATGTGACAAACCAGAAGA [31]
R:CAGAAAGTCCTGAGCACAATTCC
IFNγ F: TCAAAGTGATGAATGATCTCTCACC ”
R: GCCGGGAAACACACTGTGAC
TNFα F: CCAGATGGCCTCCAACTAATCA ”
R: GGCTTGTCACTTGGAGTTCGA
IL-6 F: AGTGGCTGAAACACGTAACAATTC ”
R: ATGGCCCTCAGGCTGAACT
CCL5 F: GCTGCTTTGCCTACATTTCC ”
R: CCCATTTCTTCTGTGGGTTG
CXCL8 F: AAGCAGGAAAACTGCCAAGAGA ”
R: GCCAGAAGAAACCTGACCAAAG
CXCL10 F: CTTTGAACCAAAGTGCTGTTCTTATC ”
R: GCGTGTAGTTCTAGAGAGAGGTACTC




β-actin F: GCAGGTCATCACCATCG [Genbank: AF038150]
R: TGGAGTTGAAGGTGGTCT
IL-1α F: GGGAAACTACCTCATGGC [Genbank:JP011578]
R: TAGAGTCACAGGAAATTTAGAATCTT
CCL3 F: GGTCTTCTCTGCACCAT [Genbank:JP007133]
R: CCAGGCTTGGAGCATTG
CASP8 F: TTATGACTTTAGCATAGCACGGA [Genbank:JP006891]
R: GTCTCTGAAAGGCACGAT
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Phenotyping of the different inflammatory cell lineages
following IHC were performed on the lungs of the in-
fected and control animals to determine which inflam-
matory cell types were associated with the different lung
lesional patterns. Neutrophils and macrophages were de-
tected by IHC using anti-lysozyme polyclonal antibodies
(Dako, Polyclonal Rabbit Anti-Human Lysozyme EC
3.2.1.17, ref A0099), T and B cells were detected using
anti-CD3 (Dako, Polyclonal Rabbit Anti-Human CD3, n°
IS503) and anti-CD20 (Thermo Scientific, CD20 Rabbit
Polyclonal Antibody, ref RB-9013-P) polyclonal antibodies
as previously described [29,30].Cytotoxic lymphocytes and natural killer (NK) cells
were detected using the anti-CD8a (Sino Biological,
Polyclonal Rabbit anti-ferret CD8a Antibody, ref 60001-
RPO2, China) polyclonal antibody. Briefly, tissue sec-
tions were deparaffinised with xylene and rehydrated
through graded concentrations of alcohol. Endogenous
peroxidase activity was blocked by incubation with 3%
H2O2 in methanol for 30 min. Tissue sections were
rinsed in PBS and immersed in Retrieval Solution (Dako,
Target Retrieval solution 10x concentrate, n°S1699) for
antigen retrieval. Later, the slides were blocked with 2%
bovine serum albumin (85040C, Sigma-Aldrich Química,
S.A., Spain) for one hour at RT and incubated with
the primary antibody overnight at 4 °C at a dilution of
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oxidase system (Dako EnVision® + System, Peroxidase-
HRP, Dako, Denmark) was applied directly to the slides
and incubated for 30 min at RT. The reaction was devel-
oped with DAB (Sigma-Aldrich, Madrid, Spain) at RT,
followed by counterstaining with Mayer’s haematoxylin.
Ferret lymph node sections were used as positive con-
trols. The same sections in which the specific primary
antibodies were substituted with PBS were used as nega-
tive controls.
Semiquantitative assessments of the inflammatory
cells detected in the lungs were also performed. The
cells that were positive in the IHC for the anti-lysozyme
(macrophages and neutrophils), anti-CD3 (T cells), anti-
CD8a (cytotoxic T cells and NK cells) and anti-CD20
(B cells) antibodies were quantified for every animal
and antibody. Positive cells in 6 arbitrarily chosen 40×
objective fields in alveolar areas and 5 arbitrarily chosen
40× objective fields in bronchi or bronchiolar areas were
counted separately for each lobe (cranial, medial and
caudal) of every animal. The means of the total cell
counts per field across the three lung lobes were then cal-
culated for each animal and antibody.
Cytokine and TLR gene expression profiles
The gene expressions of interferon (IFN) α, IFNγ, TNFα,
interleukin (IL) 6, IL-1α, CXCL8, CCL5, CXCL10, CCL3,
CCL2 and TLR3 were detected by RT-qPCR. Briefly,
RNA extraction was performed on the ferret lung tissue
samples with an RNeasy Mini Kit using the RNA sta-
bilisation and on-column DNase digestion protocols
(Qiagen). Reverse transcription was performed using
an ImProm-II reverse transcription system (Promega)
at 0.5 μg RNA. PCR was performed using a Power
SYBR green kit (Applied Biosystems) and Fast 7500 equip-
ment (Applied Biosystems). PCR reactions were per-
formed in 10 μL reaction volumes using the Power SYBR
green kit (Applied Biosystems); 40 amplification cycles
were used, and the annealing temperature was 60°. The
expression levels were normalised using the house-
keeping gene β-actin, and the results are expressed as ar-
bitrary units. The primer sequences and their publication
sources are presented in Table 1. Primer sequences for
the β-actin, IL-1α and CCL3 genes were designed as de-
scribed previously [31]. The ferret-specific genes are
available in the NCBI nucleotide database [32]. The de-
signed primer sequences and the GenBank accession
numbers are presented in Table 1. The amplification
products were detected by electrophoresis to validate
the sizes of the product in accordance with the primer
design, and the products were purified using a QIAquick
PCR Purification Kit (Qiagen). Sequencing reactions were
performed with ABI Prism BigDye Terminator Cycle
Sequencing v.3.1 Ready Reaction (Applied Biosystems)and analysed using an ABI PRISM model 3730 auto-
mated sequencer (Applied Biosystems). The amplified
sequences correlated with the ferret specific target
sequences.
Apoptotic cell detection and quantification
The expression of the proapoptotic genes caspase 8
(CASP8) and BAX were quantified by RT-qPCR. The
primer sequences are presented in Table 1. The RT-
qPCR techniques were performed as previously de-
scribed [31]. Briefly, RNA extraction was performed on
the ferret lung tissue samples with an RNeasy Mini Kit
using the RNA stabilisation and on-column DNase di-
gestion protocols (Qiagen). Reverse transcription was
performed using an ImProm-II reverse transcription sys-
tem (Promega) at 0.5 μg RNA. PCR was performed using
a Power SYBR green kit (Applied Biosystems) and Fast
7500 equipment (Applied Biosystems). PCR reactions
were performed in 10 μL reaction volumes using the
Power SYBR green kit (Applied Biosystems); 40 amplifi-
cation cycles were used, and the annealing temperature
was 60°. The expression levels were normalised using
the house-keeping gene β-actin, and the results are
expressed as arbitrary units. Primer sequences of CASP8
and BAX were designed as described previously [31].
The designed primer sequences and the GenBank acces-
sion numbers are presented in Table 1. Primer validation
was performed as described above in the cytokine gene
expression profile section.
Apoptotic cells in the lungs were also detected by IHC
using the anti-caspase 3 polyclonal antibody (Cell Signal-
ling, Cleaved Caspase-3 (Asp175) Antibody, ref 9661) di-
luted 1:100 in PBS using Ethylenediaminetetraacetic acid
(EDTA) as the antigen retrieval method. The IHC tech-
nique was performed as described above for inflam-
matory cell immunophenotyping. Swine and ferret
lymph node sections were used as positive controls,
and the sections in which the specific primary anti-
bodies were substituted with PBS were used as nega-
tive controls.
Statistical analyses
Histopathological scores and positive cell quantification
data were expressed as the means ± the standard errors
of the mean (SEMs). The correlations between the IAV
antigen quantifications and the histopathological scores
of each animal were calculated by linear regression. Des-
pite the small number of animals used in each infectious
group, statistical analyses were performed. Comparisons
of the immunophenotypes and the IAV antigen quan-
tifications between the animals that were infected
with the R11 and the R61 viruses and comparisons
between animals with severe and mild lung lesions were
performed using a non-parametric one-way analysis of
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Mann–Whitney U test. A robust analysis (one iteration)
was used to obtain the means ± the SEMs for the RT-
qPCR data. RT-qPCR comparisons between animals in-
fected with the R11 and the R61 viruses and comparison
between animals with severe and mild lung lesions were
performed using Student’s t-tests. In all cases, the results
were considered statistically significant when the P value
was < 0.05. All statistical analyses and data visualisa-
tion were performed with GraphPad Prism 6 (GraphPad
Software, La Jolla, CA, USA).
Results
Clinical signs
Two animals infected with the R61 virus and two ani-
mals infected with the R11 virus began to present with
anorexia, depression and tachypnea at 2 days post infec-
tion (dpi).
Of these four animals, one animal infected with the
R11 virus died at 4 dpi, and one animal infected with the
R61 virus had to be sacrificed at 4 dpi for ethical rea-
sons. Animals showing more severe clinical signs also
presented higher body weight loss (data not shown)
which also correlated with more severe pathological
findings in the lungs. Temperature was not affected by
viral group or by disease severity (data not shown).
Gross lesions and histopathology
Gross pathological changes were observed mainly in the
lungs of the infected animals that were necropsied at 4
dpi. One and two ferrets infected with the R11 and R61
viruses, respectively, presented with macroscopic lung
lesions. The macroscopic lesions were characterised by
heavy, firm, red and oedematous lungs. The animals in
the control group did not exhibit any gross or histo-
pathological changes.
The pulmonary histopathological scores are presented
in Table 2. In general, the three lung lobes of any given
animal were equally affected. No major differences in
terms of histopathological scores were observed between
the viral groups. Two animals infected with the R11
viral strain and two animals infected with R61 viral
strain presented with severe lung lesions that were
characterised by severe and diffuse alveolar damage. In
general, the three lung lobes were equally affected, al-
veolar epithelial necrosis was observed, and the alveoli
were distended and contained dense proteinaceous
debris, desquamated cells, and high numbers of mac-
rophages and neutrophils; in some cases, alveolar haem-
orrhage and hyaline membranes were also observed
(Figure 1).
The remaining infected animals (two infected with the
R11 virus and two infected with the R61 virus) presented
with mild lung lesions that consisted of moderate tosevere bronchial, bronchiolar and glandular necrosis
with lymphoplasmacytic inflammation (Figure 1). The
histopathological lesions observed at 7 dpi were similar
to those described at 4 dpi but also included bronchiolar
epithelial regeneration (data not shown).
The trachea and nasal turbinates were also microscop-
ically examined. In general, the ferrets that presented
with severe lung lesions also presented with necrotising
rhinitis with mucous and tracheitis with a lymphoplas-
macytic infiltration. The ferrets that presented with mild
lesions also presented with lesions in the trachea and
nasal turbinates that were characterised by a catarrhal
rhinitis with mucous secretion and tracheal glandular
necrosis (data not shown).
Viral detection and quantification
IAV antigen expression was only detected in the lungs of
the infected animals at 4 dpi, and no differences in IAV
expression, as quantified by IHC (Additional file 1A) or
RT-qPCR, were observed between animals in the R11
and R61 viral groups (Additional file 1B).
Interestingly, IAV antigen quantifications in the lungs
were significantly correlated with the histopathological
scores of the infected animals (Figure 2A). Higher viral
antigen quantifications and higher viral loads (Figure 2B
and C) were observed in the lungs of the animals that
presented with severe lung lesions than in those that
presented with mild lung lesions at 4 dpi.
The animals that developed severe lung lesions exhib-
ited viral antigen expression in bronchi/bronchiole epi-
thelial cells and scattered expression in the alveolar
parenchyma. Positive labelling was observed in the nu-
clei of type II pneumocytes and, to a lesser extent, in the
type I pneumocyte nuclei and the nuclei and cyto-
plasm of macrophages and interstitial lymphocytic cells
(Figure 1). In contrast, IAV antigen expression in the
animals that developed mild lung lesions was restricted
to the bronchi and bronchiolar areas (Figure 1), in
which IAV antigens were mainly detected in the nuclei
of the bronchi or bronchiolar epithelial and glandular
cells.
Immunophenotyping and quantification of lung
inflammatory cells
Quantifications of the different inflammatory cell popu-
lations for the animals grouped by histopathological
score are illustrated in Figure 3.
Inflammatory cell averages were higher in the lungs
of infected animals than in those of the control group.
In general, lysozyme (Lys) positive cells were the most
abundantly observed cells in the lungs of the infected
animals, and the maximum cell counts were observed
at 4 dpi. The lungs of the ferrets that presented with
severe lung lesions exhibited elevations in lysozyme + cell
Table 2 Characteristics of the experimental infection of ferrets with two different pH1N1 influenza viruses: viral
inoculums, histopathological scores and pathological classifications
Animal Sex Viral inoculums Days post infection Histopathological scorea Pathological classification
A Male R11 4† 2.67 (0.47) Severe
B Male R11 4 1 (0.00) Mild
C Female R61 4 3 (0.00) Severe
D Female R61 4 1 (0.00) Mild
E Male R61 4 3 (0.00) Severe
F Male R11 7 3 (0.00) Severe
G Male R11 7 1.67 (0,94) Mild
H Male R61 7 1 (0.00) Mild
I Female PBS Control 0 (0.00) Control
J Male PBS Control 0 (0.00) Control
†Animal found dead.
aMean and SEM of the histopathological scores of the three right lung lobes.
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compartments compared to the animals with mild lung
lesions (Figure 3), particularly in the alveolar areas
(Figure 4).
The CD3+ and CD8+ cell averages of the infected ani-
mals were higher at 7 dpi than at 4 dpi. More import-
antly, the CD3+ and CD8+ cell counts were higher in
the ferrets that developed severe lung lesions (Figure 3),
and this finding was particularly striking for the alveolarFigure 1 Pulmonary histopathological lesions in pH1N1-infected ferre
bronchiolar areas for R11 and R61 viruses. HE and immunohistochemical stCD3+ cell averages (Figure 4). The CD8+ bronchial cell
averages were similar in the animal that exhibited severe
and mild lung lesions at 7 dpi.
In contrast to the observations regarding CD3+ and
CD8+ cell quantifications, the CD20+ cell averages
decreased in both histopathological groups at 7 dpi
(Figure 3). In general, the CD20+ cell averages were the
lowest among all of the inflammatory cells (Figure 4). The
animals that presented with severe lung lesions exhibitedts at 4 dpi. Pictures show different severity of lesions in alveolar and
aining for IAV antigen (40x objective field).
Figure 3 Immunohistochemical quantification of inflammatory cells in ferret lungs infected with pH1N1 IAV. Results express the mean
cell counts with SEM (40× objective field) for lysozyme, CD3, CD8 and CD20-positive cells. Animals are segregated by histopathological score.
Figure 2 Relation between histopathological score and quantification of viral antigen in pH1N1-infected ferrets. (A) Linear regression
shows the correlation between IAV antigen quantification and histopathological scores at 4 dpi, independently of viral strains (*p value < 0.05).
(B) Relation between viral load measured by RT-PCR and histopathological score; GEC of plasmid per gram of lung tissue. (C) Immunohistochemical
cell quantification of IAV-positive cells in ferret lungs segregated by histopathological score; Results express the mean cell counts with SEM
(20× objective field).
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Figure 4 Immunohistochemical caracterization of inflammatory cell populations in ferret lungs infected with pH1N1 IAV at 4 dpi.
IHC stain for positive cells. Haematoxylin counterstain (40× objective field).
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http://www.veterinaryresearch.org/content/45/1/85slightly higher bronchial CD20+ cell counts at 4 dpi but
not at 7 dpi (Figure 3).
Cytokine and TLR gene expression profiles
To determine the relationships between the observed
immunophenotypes, the different pathological outcomes
and the cytokine, chemokine and TLR gene expressions,
RT-qPCR was performed. Both infected groups exhibited
elevated gene expression of pro-inflammatory markers
and TLR3 compared to the control group at both 4 and
7 dpi (data not shown). The gene expression profiles
of the lungs of the animals that presented with severe
lung lesions exhibited increased expressions of CXCL8,
CCL3, IFNγ, CXCL10, IL-1α, CCL5, IL-6 and TLR3
compared to those of the animals that presented with
mild lung lesions at both 4 dpi (Figure 5) and 7 dpi (data
not shown). Interestingly, at 4 dpi, a statistically signifi-
cant elevation in the induction of IFNα was observed in
the lungs of the animals that presented with mild lung
lesions (Figure 5B). No differences in CCL2 expres-
sion were observed between the pathological groups
(Figure 5C). The expressions of all cytokines decreased in
both pathological groups at 7 dpi with the exceptions of
CCL2 and TLR3 in the animals with severe lung lesions
(data not shown).Apoptotic cell detection and quantification
The apoptotic genes BAX and CASP8 in the lungs of the
infected animals were analysed with RT-qPCR. The gene
expressions of BAX and CASP8 were elevated in both in-
fected groups compared to the control group (data not
shown). However, comparison of the apoptotic induction
in the lungs of the animals that presented with different
grades of lung pathology revealed that the animals with se-
vere lung lesions exhibited elevations in the inductions of
both apoptotic markers compared to the animals with mild
lung lesions at both 4 and 7 dpi (Figure 6A).
To determine which cells were involved in the increases
in pro-apoptotic gene expression in the animals with se-
vere lung lesions, IHC using the anti-caspase 3 antibody
was performed. As expected, the numbers of apoptotic
cells were elevated in the ferrets with severe lung lesions
compared to the animals with mild lesions, but the positive
cells were mainly consistent with macrophages and neutro-
phils (Figure 6B and C), which accords with the phagocytic
cell averages observed in each pathological group.
Discussion
The pathogenic features of severe IAV infection result
from complex and dynamic processes that involve vari-
ous components of the host immune system and their
Figure 5 RT-qPCR quantification of the genes expressed in pH1N1-infected ferrets with severe and mild lung lesions. Comparisons of
the cytokine, chemokine and TLR3 gene expression levels in lungs at 4 dpi. Gene expression of IL-1α, CCL3 and CXCL10 (A); CXCL8, IL-6, CCL2
and CCL5 (B) and IFN-α, IFN-γ and TLR3 (C). The data is presented as the means and the SEMs, (*p value < 0.05).
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virus and host response characteristics in individuals who
develop mild or severe disease is important for the future
development of therapeutic strategies for cases of severe
influenza infection.Figure 6 Gene expressions of proapoptotic genes and IHC of apoptotic c
of BAX and CASP8 gene expression levels in lungs with both severe and mild le
(B) and (C) IHC staining for caspase3 in the lungs of the ferrets with mild (B) anIn this study, ferrets were infected with two pH1N1
isolates from two patients who developed significantly
different clinical outcomes. Although the number of ani-
mals used in each infectious group is limited, our results
demonstrated that the virulences of the pH1N1 strainsells in lungs of pH1N1-infected ferrets at 4 and 7 dpi. (A) Comparison
sions as measured by RT-qPCR. The data expresses the means with SEMs.
d severe (C) lesions; haematoxylin counterstain (40× objective field).
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http://www.veterinaryresearch.org/content/45/1/85in ferrets were not associated with the clinical pheno-
types of the corresponding human patients. Similar find-
ings have been described by other studies that have used
animal models that have been infected with pH1N1 iso-
lates from patients who exhibited diverse degrees of dis-
ease severity [9,33]. Indeed, the severity of infection in
ferrets can range from a sublethal infection with mild
symptoms to lethality rates of 30-50% [5,34,35]; this vari-
ability suggests the importance of the influences of both
differences in viral strains and individual host variability
on the severity of infection.
A previous study that employed the viral isolates used
in this trial showed differences in the in vitro and in vivo
characteristics of the two strains. In that study, the R11
strain exhibited higher in vitro replication rates between
9 and 24 hours post infection and 2 dpi in mice, and this
difference was accompanied by more severe pathological
lesions relative to those induced by the R61 strain [11].
As previously stated, in this study, the virulence of the
R11 isolate was not consistently observed in ferrets, and
more surprisingly, the R61 strain induced unexpectedly
high viral titres in the lungs that were associated with
severe pathological lesions in two animals. These contra-
dictory results may be attributable to the following ex-
planations: i) the mouse model may not be the most
suitable model for assessing influenza virus pathogen-
icity [36–38], and ii) ferrets, as an outbreed animal, may
exhibit differential individual susceptibilities to viral in-
fection. In humans, the genetic factors of the host are
increasingly being linked to disease courses [12,13]. Host-
specific characteristics, such as the presence of homozy-
gous CCR5 deleterious alleles (CCR5D32), have been
found to be associated with poor outcomes of pH1N1 in-
fection [14–16,20]. Interestingly, the patient from which
the R11 virus was isolated was recently found to have this
genotype [11].
Our results revealed a significant correlation between
lung lesional score and virus quantification in the lung
that was independent of the viral strain that was inocu-
lated. This finding led us to further investigate the im-
mune responses and viral kinetic patterns by grouping
the animals according to lung lesion severity rather than
only considering the infecting viral strain.
Viral quantifications and localisations of the viral anti-
gens in the lung compartments differed between indi-
viduals that were infected with the same virus but
correlated with the severity of the lung lesions. Interest-
ingly, in the animals that developed severe lung lesions,
the viral antigen was observed in the alveolar areas,
which suggests that sustained viral replication in the al-
veolar parenchyma was critical for the establishment of
severe pathology; this suggestion has previously been
made by Kuiken et al. [39]. In contrast, the animals that
developed mild lung lesions did not present with IAVantigens in the alveolar areas and their viral quantifica-
tions were significantly lower.
Although viral replication is fundamental in determin-
ing the severity of the disease, the inflammatory re-
sponse to the presence of the virus also plays important
roles in tissue damage and pathological outcomes [40].
The induction of proinflammatory cytokines and chemo-
kines after influenza infection is known to promote re-
spiratory tract inflammation by recruiting inflammatory
cells to the site of infection [41]. In this work, we found
that the ferrets that developed severe lung lesions exhib-
ited elevated expressions of proinflammatory cytokines
(IL-1α, IL-6 and IFNγ) and chemoattractants (CXCL8,
CXCL10, CCL3 and CCL5), which correlated with in-
creased levels of phagocytic and T cell infiltrates in the
lungs. The most abundant cell populations were the
Lys + phagocytic cells (neutrophils and macrophages)
followed by the CD3+ and CD8+ T cell populations. The
exacerbated recruitment of neutrophils and macrophages
into the lung parenchyma and alveolar spaces is recognised
as contributing to the detrimental effects of influenza im-
munopathology via the production of pro-inflammatory
molecules and the release of reactive oxygen species and
nitric oxide [41–44].
In the present study, CD3+ and CD8+ cells were
found more abundantly in the ferrets that exhibited
severe lesional pattern that were accompanied with ele-
vations in the inductions of IFNγ, CCL5 and CCL3.
Several studies have shown that NK and CD8 T cells
concentrations increase in mouse and human lungs fol-
lowing severe influenza infection both in the early stages
of influenza infection and the later viral clearance stage
[41,45–49]. Moreover, the suppression of the early in-
nate cell infiltration of NK and CD8 T cells has been
shown to significantly increase mouse survival rates
without altering the kinetics of viral clearance; these
findings suggest that the infiltration of these cells has a
negative inflammatory role that is independent of viral
kinetics [50,51].
Several studies have identified common cytokine gene
expression profiles that are involved in neutrophil re-
cruitment, stimulation of T cell proliferation and CD8+
cell-mediated inflammation in influenza- associated
pathology [17,52,53]. Gene expression profiles that pro-
mote T helper (Th) 1 cell responses have also been
shown to be closely related to poor outcomes in severe
cases of pH1N1 infection [17,54,55]. Here, the animals
that developed severe lung lesions also presented with
elevated expressions of Th1 response-inducers (CCL5,
CCL3, CXCL10 and IFNγ), while no differences in the
expression of the Th2 response-inducer CCL2 were ob-
served between animals with severe and mild lesions.
IFNα gene expression in the animals that developed
mild lung lesions was significantly elevated compared to
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finding suggests that IFNα has a protective role in the
early stages of infection. Supporting this supposition,
Svitek et al. found that ferrets that develop mild seasonal
influenza also exhibit increases in the expression of
IFNα [56]. Moreover, some studies of mice and ma-
caques have shown that the exogenous administration of
IFNα protects animals against influenza A and SARS
coronavirus infections [57,58].
To determine the differences in viral signalling in the
animals with different pathological outcomes, TLR3 gene
expression was measured. TLR3 is an innate immune
recognition receptor that has key roles in dsRNA detec-
tion, the initiation of innate immune responses, and the
linking of innate and adaptive immunity to limit virus
production [59]. It is known that aberrant TLR3 signal-
ling plays a key role in mediating lung pathology and
contributes to detrimental host inflammatory responses
through the induction of proinflammatory molecules
and the recruitment of CD8+ and phagocytic cells dur-
ing IAV virus infection [42,47,59–61]. Polymorphisms
that alter the function of TLR3 have been shown to be
related to severe cases of pH1N1 and H5N1 influenza
infection [20,60,62]. In the present work, the animals
that developed severe lung lesions exhibited elevated
TLR3 gene expression in the lungs that correlated with
increased viral quantifications and increased recruitment
of CD8+ and Lys + cells in these animals. However, the
severely ill animals exhibited significantly lower expres-
sions of IFNα, which is up-regulated by TLR3 induction.
Nevertheless, this striking phenomenon may be indica-
tive of inappropriate functioning of either the TLR3 or
the Interferon receptor (IFNR)1 or impairments of the
TLR3-IFNR1 pathway.
Yang et al. [63] have recently demonstrated that
pH1N1 can induce caspase-3-dependent apoptosis in al-
veolar epithelial cells (AEC). In our study, the animals
with severe lung lesions presented with increased induc-
tions of both the BAX and CASP8 pro-apoptotic genes
in the lungs. However, immunohistopathological ana-
lyses revealed that apoptotic cells at 4 and 7 dpi were
mainly identified as macrophages and neutrophils. This
finding may elucidate another mechanism of lung tissue
damage that is mediated by a delayed clearance of in-
flammatory cells from infected lungs. The occurrence of
complete resolution of inflammation requires apoptotic
neutrophils to be cleared by local tissue macrophages.
However, if either neutrophil apoptosis or the clearance
of apoptotic neutrophils by macrophages is delayed,
inflammation-related tissue damage occurs and leads
to the exacerbation of inflammation [64,65] due to in-
creased numbers of inflammatory cells in apoptosis and
increased gene expression of BAX and CASP8 that were
observed in the ferrets with severe lung lesions. Moreover,these findings are likely related to the delayed viral clear-
ance and the positive feedback loop of proinflammatory
cytokines.
This study represents an exhaustive characterisation of
the inflammatory cell populations and proinflammatory
gene expression profiles in the lungs of pH1N1-infected
ferrets. Additionally, despite the limited number of ani-
mals used, we provided further evidence regarding the
implications of viral replication efficiency, inflammatory
cytokine induction, and phagocytic and cytotoxic cell in-
filtration in influenza-infected lungs that are associated
with pathology at the time of the switch from the innate
to the adaptive immune response. More importantly,
our results support the notion that viral replication and
the correct orchestration of the early inflammatory re-
sponse are key factors in the development of severe
influenza.
Additional file
Additional file 1: Pulmonary IAV antigen quantification and viral
load in ferrets infected with R11 and R61 pH1N1 viruses.
(A) Immunohistochemical quantification; results express the mean cell
counts with SEM (20x objective field). (B) Viral load is measured by
RT-qPCR. GEC of plasmid per gram of lung tissue.
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